Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models
Biomarkers of the Exhaled Breath and Single-Lead Electrocardiography in the Diagnosis of Myocardial Ischemia
Sponsor: I.M. Sechenov First Moscow State Medical University
Listed as NCT06181799, this observational or N/A phase trial focuses on Angina Pectoris and Chronic Coronary Disease and remains completed. Sponsored by I.M. Sechenov First Moscow State Medical University, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Nov 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- I.M. Sechenov First Moscow State Medical University
For direct contact, visit the study record on ClinicalTrials.gov .